Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€151.76

€151.76

2.590%
3.36
2.590%
€157.00

€157.00

 
Latest predictions
-
11.02.21
buy
-
28.01.21
buy
-
09.01.21
buy
€159.00
05.01.21
buy
-
24.11.20
buy
€155.00
03.10.20
buy
Your prediction

3M Company Stock

3M Company gained 2.590% today.
We see a rather positive sentiment for 3M Company with 13 Buy predictions and 2 Sell predictions.
As a result the target price of €157.00 shows a slightly positive potential of 3.453% compared to the current price of €151.76 for 3M Company.
For the coming years our community has positive and negative things to say abot the 3M Company stock. Criterium "Management" gathered the most positive votes but regarding "Management" there were negative voices in the community.

Pros and Cons of 3M Company in the next few years

Pros
0
-
Cons
1
Below average Management
1
Probably not worthwhile Investment

Performance of 3M Company vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
3M Company 2.590% 4.547% 2.154% 11.670% 6.603% -19.491% 4.086%
Honeywell International 1.430% 3.375% 2.957% 19.490% 1.618% 45.906% 77.373%
Illinois Tool Works 2.760% 5.131% 5.043% 21.414% 7.596% 35.815% 98.111%
General Electric Co. 0.650% 9.810% 20.710% 37.550% 32.168% -2.075% -58.284%

Comments

Buy 3M Company

Sell 3M Company

Prediction Buy
Perf. (%) -9.89%
Target price 160.000
Change
Ends at 21.08.20

Buy with target price 160.0

Other discussions about 3M Company Stock

Trading 3M Company

Trading 3M Company

New thread Forum

News

New Data from PROMISES Study Shows PREVENA™ Incision Management System Significantly Reduces Major Complications and Readmissions Compared to Standard of Carehttp://commons.wikimedia.org/wiki/File:3M_wordmark.svg#filehistory: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11080/300px-3M_wordmark.svg.png
New Data from PROMISES Study Shows PREVENA™ Incision Management System Significantly Reduces Major Complications and Readmissions Compared to Standard of Care


3M today announced new data demonstrating the PREVENA™ Incision Management System significantly mitigated 90-day surgical site complications (SSCs) and readmission rates in patients undergoing